Smoking and early COPD as independent predictors of body composition, exercise capacity, and health status

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Caram, Laura Miranda De Oliveira ^a   Ferrari, Renata ^a   Bertani, André Luís ^a   Garcia, Thaís ^a   Mesquita, Carolina Bonfanti ^a   Knaut, Caroline ^a   Tanni, Suzana Erico ^a   Godoy, Irma ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY COMPOSITION; BRAZILIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; EMOTIONALITY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; MALE; OUTCOME ASSESSMENT; PREDICTION; SMOKING; AGED; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; REGRESSION ANALYSIS; SPIROMETRY; WALK TEST;

AGED; BODY COMPOSITION; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; SMOKING; SPIROMETRY; WALK TEST;

EID: 84991288252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164290     Document Type: Article

References (57)

1. WHO. Chronic respiratory disease. In: World Health Organization. disease.wwwwhoint/en. Accessed 20 Oct 2015.
2. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007; 131(5):1557-66. doi: 10.1378/chest.06-2179 PMID: 17494805
3. GOLD. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary update 2015. wwwgoldcopdorg. Accessed 15 Sep 2015.
4. Roca J, Vargas C, Cano I, Selivanov V, Barreiro E, Maier D et al. Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management. J Transl Med. 2014; Suppl 2: :S3. doi: 10.1186/1479-5876-12-S2-S3 PMID: 25472887
5. Wüst RC, Morse CI, de Haan A, Rittweger J, Jones DA, Degens H. Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol. 2008; 104(1):103-10. doi: 10.1007/s00421-008-0792-9 PMID: 18560879
6. Degens H, Gayan-Ramirez G, van Hees HW. Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms. Am J Respir Crit Care Med. 2015; 191(6):620-25. doi: 10.1164/rccm.201410-1830PP PMID: 25581779
7. Furlanetto KC, Mantoani LC, Bisca G, Morita AA, Zabatiero J, Proença M et al. Reduction of physical activity in daily life and its determinants in smokers without airflow obstruction. Respirology. 2014; 19 (3):369-75. doi: 10.1111/resp.12236 PMID: 24483840
8. Mesquita R, Gonçalves CG, Hayashi D, Costa VeS, Teixeira DeC, de Freitas ER et al. Smoking status and its relationship with exercise capacity, physical activity in daily life and quality of life in physically independent, elderly individuals. Physiotherapy. 2015; 101(1):55-61. doi: 10.1016/j.physio.2014.04.008 PMID: 25108641
9. Martinez JA, Mota GA, Vianna ES, Filho JT, Silva GA, Rodrigues AL. Impaired quality of life of healthy young smokers. Chest. 2004; 125(2):425-8. PMID: 14769719
10. Clark CJ, Cochrane LM, Mackay E, Paton B. Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training. Eur Respir J. 2000; 15(1):92-7. PMID: 10678627
11. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010; 36 (1):81-8. doi: 10.1183/09031936.00104909 PMID: 19897554
12. O'Donnell DE, Gebke KB. Activity restriction in mild COPD: a challenging clinical problem. Int J Chron Obstruct Pulmon Dis. 2014; 9:577-88. doi: 10.2147/COPD.S62766 PMID: 24940054
13. Foschino Barbaro MP, Carpagnano GE, Spanevello A, Cagnazzo MG, Barnes PJ. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol. 2007; 20(4):753-63. PMID: 18179748
14. Genç A, Üçok K, Şener Ü, Koyuncu T, Akar O, Çelik S et al. Association analyses of oxidative stress, aerobic capacity, daily physical activity, and body composition parameters in patients with mild to moderate COPD. Turk J Med Sci. 2014; 44(6):972-9. PMID: 25552149
15. Puig-Vilanova E, Ausin P, Martinez-Llorens J, Gea J, Barreiro E. Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease? PLoS One. 2014; 9 (7):e102296. doi: 10.1371/journal.pone.0102296 PMID: 25013984
16. Eliason G, Abdel-Halim S, Arvidsson B, Kadi F, Piehl-Aulin K. Physical performance and muscular characteristics in different stages of COPD. Scand J Med Sci Sports. 2009; 19(6):865-70. doi: 10.1111/j.1600-0838.2008.00858.x PMID: 18980606
17. Díaz AA, Morales A, Díaz JC, Ramos C, Klaassen J, Saldías F et al. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. Respir Med. 2013; 107(4):570-9. doi: 10.1016/j.rmed.2012.12.011 PMID: 23313036
18. Negi H, Sarkar M, Raval AD, Pandey K, Das P. Health-related quality of life in patients with chronic obstructive pulmonary disease in North India. J Postgrad Med. 2014; 60(1):7-11. doi: 10.4103/0022-3859.128797 PMID: 24625932
19. Wacker ME, Hunger M, Karrasch S, Heinrich J, Peters A, Schulz H et al. Health-related quality of life and chronic obstructive pulmonary disease in early stages-longitudinal results from the population-based KORA cohort in a working age population. BMC Pulm Med. 2014; 14:134. doi: 10.1186/1471-2466-14-134 PMID: 25107380
20. Janson C, Marks G, Buist S, Gnatiuc L, Gislason T, McBurnie MA et al. The impact of COPD on health status: findings from the BOLD study. Eur Respir J. 2013; 42(6):1472-83. doi: 10.1183/09031936.00153712 PMID: 23722617
21. Wu L, Ma L, Nicholson LF, Black PN. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med. 2011; 105(3):329-36. doi: 10.1016/j.rmed.2010.11.001 PMID: 21112201
22. Hoonhorst SJ, Lo Tam Loi AT, Hartman JE, Telenga ED, van den Berge M, Koenderman L, et al. Advanced glycation end products in the skin are enhanced in COPD. Metabolism. 2014; 63(9):1149-56. doi: 10.1016/j.metabol.2014.06.006 PMID: 25034386
23. Vernooy JH, Küçükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med. 2002; 166(9):1218-24. doi: 10.1164/rccm.2202023 PMID: 12403691
24. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987; 136(5):1285-98. doi: 10.1164/ajrccm/136.5.1285 PMID: 3674589
25. Pereira C, Barreto S, Simões J, Pereira F, Gerstler J, Nakatani J. Valores de referência para a espirometria em uma amostra da populaçäo brasileira adulta. J Bras Pneumol. 1992; 18: 10-22.
26. Reichert J, Araújo A, Gonçalves C, Godoy I, Chatkin J, Sales M. Diretrizes para cessação do tabagismo. J Bras Pneumol. 2008; 34:845-80.
27. Middleton ET, Morice AH. Breath carbon monoxide as an indication of smoking habit. Chest. 2000; 117(3):758-63. PMID: 10713003
28. Santos U, Gannam S, Abe J, Esteves P, Filho M, Wakassa T. Emprego da determinação de monóxido de carbono no ar exalado para a detecção do consumo de tabaco. J Bras Pneumol. 2001; 27: 231-6.
29. Borg: Escala CR10 de Borg. In: Borg G. Escala de Borg para dor e esforço percebido, 1 edn. São Paulo; 2000.
30. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM et al. Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr. 2004; 23(5):1226-43. doi: 10.1016/j.clnu.2004.06.004 PMID: 15380917
31. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005; 82(1):53-9. PMID: 16002800
32. Crapo R, Casaburi R, Coates A, Enright P, MacIntyre N, McKay R. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166: 111-7. doi: 10.1164/ajrccm.166.1.at1102 PMID: 12091180
33. Iwama AM, Andrade GN, Shima P, Tanni SE, Godoy I, Dourado VZ. The six-minute walk test and body weight-walk distance product in healthy Brazilian subjects. Braz J Med Biol Res. 2009; 42(11):1080-5. PMID: 19802464
34. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am. 1984; 9(2):222-6. PMID: 6715829
35. Nollet F, B A. Strength assessment in postpolio syndrome: validity of a hand-held dynamometer in detecting change. Arch Phys Med Rehabil. 1990; 80: 1316-23.
36. O'Shea S, Taylor N, Paratz J. Measuring muscle strength for people with pulmonary disease: retest reliability of hand-held dynamometry. Arch Phys Med Rehabil. 2007; 88: 32-6. doi: 10.1016/j.apmr.2006.10.002 PMID: 17207672
37. Possani H, Carvalho M, Probst V, Pitta F, Brunetto A. Comparison between the reduction in muscle force in upper and lower limbs after a fatigue protocol in patients with Chronic Obstructive Pulmonary Disease (COPD). ASSOBRAFIR Ciência. 2009: 33-43.
38. Coronell C, Orozco-Levi M, Méndez R, Ramírez-Sarmiento A, Gáldiz JB, Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J. 2004; 24(1):129-36. PMID: 15293615
39. Ciconelli R, Ferraz M, Santos W, Meinão I, Quaresma M. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999; 39:143-50.
40. van den Borst B, Koster A, Yu B, Gosker HR, Meibohm B, Bauer DC et al. Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax. 2011; 66(11):961-9. doi: 10.1136/thoraxjnl-2011-200010 PMID: 21724748
41. Boyer L, Chouaïd C, Bastuji-Garin S, Marcos E, Margarit L, Le Corvoisier P et al. Aging-related systemic manifestations in COPD patients and cigarette smokers. PLoS One. 2015; 10(3):e0121539. doi: 10.1371/journal.pone.0121539 PMID: 25785739
42. Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr. 2005; 82(5):996-1003. PMID: 16280430
43. Rutten EP, Calverley PM, Casaburi R, et al. Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes? Ann Nutr Metab. 2013; 63(3):239-47. doi: 10.1159/000353211 PMID: 24216978
44. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008; 87(4):801-9. PMID: 18400700
45. Montes de Oca M, Loeb E, Torres SH, De Sanctis J, Hernández N, Tálamo C. Peripheral muscle alterations in non-COPD smokers. Chest. 2008; 133(1):13-8. doi: 10.1378/chest.07-1592 PMID: 18187741
46. Gosker HR, van Mameren H, van Dijk PJ, Engelen MP, van der Vusse GJ, Wouters EF et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002; 19(4):617-25. PMID: 11998989
47. Maltais F, Dennis N, Chan CK. Rationale for earlier treatment in COPD: a systematic review of published literature in mild-to-moderate COPD. COPD. 2013; 10(1):79-103. doi: 10.3109/15412555.2012.719048 PMID: 23272663
48. Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015; 14(1):58-74. doi: 10.1038/nrd4467 PMID: 25549588
49. Langen RC, Gosker HR, Remels AH, Schols AM. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 2013; 45(10):2245-56. doi: 10.1016/j.biocel.2013.06.015 PMID: 23827718
50. Steiner MC, Evans R, Deacon SJ, Singh SJ, Patel P, Fox Jet al. Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax. 2005; 60(11):932-6. doi: 10.1136/thx.2004.038802 PMID: 16055624
51. McDonough P, Moffatt RJ. Smoking-induced elevations in blood carboxyhaemoglobin levels. Effect on maximal oxygen uptake. Sports Med. 1999; 27(5):275-83. PMID: 10368876
52. Cooper CB: Airflow obstruction and exercise. Respir Med. 2009; 103(3):325-34. doi: 10.1016/j.rmed.2008.10.026 PMID: 19071004
53. Sales MP, Oliveira MI, Mattos IM, Viana CM, Pereira ED. The impact of smoking cessation on patient quality of life. J Bras Pneumol. 2009; 35(5):436-41. PMID: 19547852
54. Meerwaldt R, Links T, Zeebregts C, Smit A. Re: "plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies". Am J Epidemiol. 2008; 167(6):756-7. doi: 10.1093/aje/kwn018 PMID: 18296707
55. Northrop-Clewes CA, Thurnham DI. Monitoring micronutrients in cigarette smokers. Clin Chim Acta. 2007; 377(1-2):14-38. doi: 10.1016/j.cca.2006.08.028 PMID: 17045981
56. Saravanan C, Heidhy I. Psychological problems and psychosocial predictors of cigarette smoking behavior among undergraduate students in Malaysia. Asian Pac J Cancer Prev. 2014; 15(18):7629-34. PMID: 25292039
57. Bjørngaard JH, Gunnell D, Elvestad MB, Davey Smith G, Skorpen F, Krokan H et al. The causal role of smoking in anxiety and depression: a Mendelian randomization analysis of the HUNT study. Psychol Med. 2013; 43(4):711-9. doi: 10.1017/S0033291712001274 PMID: 22687325